OmniAb (OABI) Common Equity (2021 - 2026)
OmniAb (OABI) reported Common Equity of $260.27 million for Q2 2026, down 0.7% from $262.06 million a year earlier and down 0.9% from the prior quarter.
Analysis
OmniAb (OABI) Common Equity (2021 - 2026) Analysis & Trends
At the end of FY2025, OmniAb posted Common Equity of $267.03 million, down 7.2% from FY2024.
- Common Equity has declined for three consecutive years, though with a four-year compound annual growth rate of 3.3% (FY2021 to FY2025).
- By year, Common Equity came in at $287.62 million in FY2024 (-8.6%), $314.59 million in FY2023 (-7.8%), $341.37 million in FY2022 (+45.7%) and $234.31 million in FY2021.
- The Q2 2026 figure ranks as the lowest quarterly Common Equity since Q3 2022.
- Year over year, Common Equity has now declined in each of the last 11 quarters, with an average decline of 6.9% over the last eight quarters.
- The high point for year-over-year Common Equity in five years was Q1 2023 (growth of 51.5%); the low point was Q2 2024 (a decline of 11.9%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $262.65 million (Q1 2026), $267.03 million (Q4 2025) and $277.44 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | OmniAb | 689.15 Mn | 474.56 Mn | 12.81 Mn | 260.27 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 260.27 Mn |
| Mar 31, 2026 | 262.65 Mn |
| Dec 31, 2025 | 267.03 Mn |
| Sep 30, 2025 | 277.44 Mn |
| Jun 30, 2025 | 262.06 Mn |
| Mar 31, 2025 | 273.52 Mn |
| Dec 31, 2024 | 287.62 Mn |
| Sep 30, 2024 | 291.73 Mn |
| Jun 30, 2024 | 294.18 Mn |
| Mar 31, 2024 | 301.39 Mn |
| Dec 31, 2023 | 314.59 Mn |
| Sep 30, 2023 | 324.55 Mn |
| Jun 30, 2023 | 333.81 Mn |
| Mar 31, 2023 | 340.80 Mn |
| Dec 31, 2022 | 341.37 Mn |
| Sep 30, 2022 | 232.71 Mn |
| Jun 30, 2022 | 226.94 Mn |
| Mar 31, 2022 | 224.92 Mn |
| Dec 31, 2021 | 234.31 Mn |
| Sep 30, 2021 | -6.90 Mn |
API Access
OmniAb Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=OABI&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "OABI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=OABI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();